Does GEMFIBROZIL Cause Therapy cessation? 6 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Therapy cessation have been filed in association with GEMFIBROZIL (Gemfibrozil). This represents 0.6% of all adverse event reports for GEMFIBROZIL.
6
Reports of Therapy cessation with GEMFIBROZIL
0.6%
of all GEMFIBROZIL reports
0
Deaths
1
Hospitalizations
How Dangerous Is Therapy cessation From GEMFIBROZIL?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMFIBROZIL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does GEMFIBROZIL Cause?
Drug hypersensitivity (242)
Drug ineffective (77)
Rhabdomyolysis (63)
Fatigue (60)
Drug interaction (59)
Myalgia (58)
Nausea (54)
Acute kidney injury (52)
Diarrhoea (43)
Rash (41)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which GEMFIBROZIL Alternatives Have Lower Therapy cessation Risk?
GEMFIBROZIL vs GEMTUZUMAB OZOGAMICIN
GEMFIBROZIL vs GEMZAR
GEMFIBROZIL vs GENTAMICIN
GEMFIBROZIL vs GEODON
GEMFIBROZIL vs GILENYA